MANA RBM's network of clinical researchers reported that research sites are eliminating onsite monitoring visits. If onsite monitoring visits are a Sponsor's main oversight approach, the solution to this critical problem is available now.
MANA RBM provides remote, automated risk-based monitoring (RBM) customized to a site's protocol. The company delivers its solution, customized to the areas of greatest concern, specific to a study. Subject review can begin within days.
"We recently published an example of this successful approach, adding remote Risk Based Monitoring to trials being conducted with traditional SDV," said Penny Manasco, M.D., CEO of MANA RBM. "Within days, we started remote subject review. Within 2 months, we identified critical errors that SDV did not find."
Here is the link to the head to head comparison:
http://www.appliedclinicaltrialsonline.com/comparing-risk-based-monitoring-and-remote-trial-management-vs-sdv
March 17, 2020
Topic Area: Press Release
Recent Posts
How Architects Shape the Future of Healthcare Facilities
Healthcare architecture is more than just designing and building hospitals.
UNC Health, Duke Health Form Partnership for Stand-alone Children's Hospital
The partners plan to break ground together on the new NC Children’s campus by 2027.
Sarasota Memorial Hospital Plans to Build New Facility in North Port
The six-story, 100-bed hospital is slated to open in fall of 2028.
CMMS, Data and the Path to Compliance
Taking control of healthcare facilities data in CMMS enables managers to use it to ensure the efficient operation and maintenance of their assets.
Healthcare is a Major Ransomware Target
Healthcare is the third-most-targeted sector, according to the report.